l-glutathione drug interactions Drug-Food with a Focus on Mediterranean Diet Glutathione-Mediated Conjugation of Anticancer Drugs:
Description
CB-839 Recently, another GLS1 selective inhibitor, CB-839 (telaglenastat), is currently undergoing comprehensive clinical trials (Fig

1990;Remarque et al

doi: 10.35946/arcr.v37.2.15

Treadway et al., 2019)
& Hernandez, A
